Ordinary Index Rebalancing in the Medical Care Growth Index | May 2022

In the ordinary rebalance the following composition will be implemented effective open 05.05.2022:

ALECTOR INC
ARVINAS INC
ATHERSYS INC
AVEO PHARMACEUTICALS INC
BEAM THERAPEUTICS INC
BIOCRYST PHARMACEUTICALS INC
BIOHAVEN PHARMACEUTICAL HOLD
CO-DIAGNOSTICS INC
CUE BIOPHARMA INC
CUTERA INC
DECIPHERA PHARMACEUTICALS INC
DYNAVAX TECHNOLOGIES CORP
EVOFEM BIOSCIENCES INC
FOGHORN THERAPEUTICS INC.
GERON CORP
GRITSTONE BIO INC
HARMONY BIOSCIENCES HOLDINGS INC
HESKA CORP
HOMOLOGY MEDICINES INC
ICU MEDICAL INC
IMMUNITYBIO INC
INOTIV INC
INTRA-CELLULAR THERAPIES INC
IRADIMED CORP
LA JOLLA PHARMACEUTICAL CO
LINEAGE CELL THERAPEUTICS INC
MEIRAGTX HOLDINGS PLC
MESA LABORATORIES INC
MIRATI THERAPEUTICS INC
MODERNA INC
OCULAR THERAPEUTIX INC
ONCOCYTE CORP
ORGANOGENESIS HOLDINGS INC
OSCAR HEALTH INC
PARATEK PHARMACEUTICALS INC
PFIZER INC
PHASEBIO PHARMACEUTICALS INC
PLX PHARMA INC
REPLIGEN CORP
REVANCE THERAPEUTICS INC
SEER INC
SENSUS HEALTHCARE INC
SERES THERAPEUTICS INC
SHOCKWAVE MEDICAL INC
SORRENTO THERAPEUTICS INC
SPERO THERAPEUTICS INC
STAAR SURGICAL CO
SYNDAX PHARMACEUTICALS INC
TANDEM DIABETES CARE INC
UROGEN PHARMA LTD
VAREX IMAGING CORP
VIR BIOTECHNOLOGY INC
XERIS BIOPHARMA HOLDINGS INC
ZOSANO PHARMA CORP